Prof. EMİNE RABİA KOÇ

Personal InformationPersonal Information
Web: htps://avesis.uludag.edu.tr/erabiakoc
International Researcher IDsInternational Researcher IDs
ORCID:0000-0002-0264-7284
YoksisResearcher ID:28139

EducationEducation

Postgraduate, Technische Universitaet Dresden, Multiple Sklerose und Leiter vom MS-Zentrum Dresden, Neurology-MS-
Neuroimmunology, Germany 2022 -Continues

Expertise InMedicine,KirikkaleUniversity,SchoolOfMedıcıne,DepartmentOf InternalMedıcıne,Turkey2003 -2008
Undergraduate,EgeUniversity,FacultyOfMedicine,Turkey1996 -2002

ResearchAreasResearchAreas
Health Sciences

Academic PositionsAcademic Positions
Professor,BursaUludağUniversity,Tıp Fakültesi,DahiliTıpBilimleri,2025 -Continues
AssociateProfessor,BursaUludağUniversity,Tıp Fakültesi,DahiliTıpBilimleri,2021 -2025
AssistantProfessor,BalikesirUniversity,SchoolOfMedıcıne,DepartmentOf InternalMedıcıne,2012 -2016
ResearchAssistant,KirikkaleUniversity,SchoolOfMedıcıne,DepartmentOf InternalMedıcıne,2003 -2008

Academic and Administrative ExperienceAcademic and Administrative Experience
Head ofDepartment,BalikesirUniversity,SchoolOfMedıcıne,DepartmentOf InternalMedıcıne,2012 -2016

Courses
UndergraduateUndergraduate
Merkezi sinir sisteminindemiyelinizanhastalıkları,Undergraduate,2023 -2024,2022 -2023
nörolojikAnamnez alma veYardımcıTanıYöntemleri,Undergraduate,2022 -2023

Journal articles indexed in SCI, SSCI, and AHCIJournal articles indexed in SCI, SSCI, and AHCI
I. Real-world experience of ocrelizumab in patients withmultiple sclerosis: A single-center studyReal-world experience of ocrelizumab in patients withmultiple sclerosis: A single-center study
KoçE.R.
NEUROLOGYASIA, vol.30,no.1,pp.251-259,2025 (SCI-Expanded)
I. Response to the leter to the editor: Long-term outcomes of infliximab treatment in neuro-BehcetResponse to the leter to the editor: Long-term outcomes of infliximab treatment in neuro-Behcet

syndrome patients: a single-center retrospective studysyndrome patients: a single-center retrospective study
KocE.R.,GülüG.,Saridas F.,Gluscevic S.,CoskunB.N.,PehlivanY.,Calikusu F.Z.,TuranO.F.
ClinicalRheumatology,vol.43,no.12,pp.4025-4026,2024 (SCI-Expanded)
II. Exploring the impact of wearing-of phenomenon in ocrelizumab-treatedmultiple sclerosis patients:Exploring the impact of wearing-of phenomenon in ocrelizumab-treatedmultiple sclerosis patients:
Insights from a comprehensive studyInsights from a comprehensive study
SeferoğluM.,TunçA.,SıvacıA.Ö.,UzunerG.T.,Mungan S., İnançY.,YETKİNM.F.,ÖztürkB.,KOÇE.R.,TürkoğluŞ.A.,
etal.
Multiple Sclerosis andRelatedDisorders, vol.92,2024 (SCI-Expanded)
IV. Coexistence of epilepsy or seizure andmultiple sclerosis; a single center experienceCoexistence of epilepsy or seizure andmultiple sclerosis; a single center experience
Saridas F.,MesutG.,OzparR.,KocE.R.,HakyemezB.,BicanDemirA.,TuranO.F.
MULTIPLE SCLEROSISANDRELATEDDISORDERS,2024 (SCI-Expanded)
V. Evaluation of risk factors for postpartum cerebral venous sinus thrombosis, amulticenterEvaluation of risk factors for postpartum cerebral venous sinus thrombosis, amulticenter
retrospective observational studyretrospective observational study
DincY.,DemirB.C.,SigirliD.,AkarsuE.O.,Saridas F.,HakyemezB.,BakarM.,GülüG.,GüneşA.,HakiC.,etal.
MEDICINE,no.49,2024 (SCI-Expanded)
VI. Efects of disease-modifying therapies on remyelination inmultiple sclerosis; evaluation via visualEfects of disease-modifying therapies on remyelination inmultiple sclerosis; evaluation via visual
evoked potential testevoked potential test
SARIDAŞ F.,HOJATIF.,ALIZADA S.,LazrakS.,KOÇE.R.,TURANÖ.F.
Multiple Sclerosis andRelatedDisorders, vol.91,2024 (SCI-Expanded)
VI. Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-centerLong-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center
retrospective studyretrospective study
KOÇE.R.,GizemG.,SARIDAŞ F.,SanjaG.,NihanC.B.,PEHLİVANY.,MİNBAY F.Z.,FarukT.O.
CLINICALRHEUMATOLOGY,vol.43,no.10,pp.3213-3221,2024 (SCI-Expanded)
VII. Characteristics of Cerebral Venous Sinus Thrombosis Due to Autoimmune DiseasesCharacteristics of Cerebral Venous Sinus Thrombosis Due to Autoimmune Diseases
SARIDAŞ F.,MESUTG.,DİNÇY.,KOÇE.R.,ÖZPARR.,HAKYEMEZB.,TURANÖ.F.
NEUROLOGIST,no.3,pp.152-157,2024 (SCI-Expanded)
IX. Prognostic factors of tumefactive demyelinating lesions and diferential features for multiplePrognostic factors of tumefactive demyelinating lesions and diferential features for multiple
sclerosis in etiologysclerosis in etiology
SARIDAŞ F.,MESUTG.,CeylanC.Y.,ÖZPARR.,ÖZŞENM.,KOÇE.R.,TOLUNAYŞ.,HAKYEMEZB.,TURANÖ.F.
Multiple Sclerosis andRelatedDisorders, vol.85,2024 (SCI-Expanded)

X. Alemtuzumab infusion-associated reactions and laboratory changes in patients with relapsing-Alemtuzumab infusion-associated reactions and laboratory changes in patients with relapsing-
remitingmultiple sclerosis at baseline and first-year folow-upremitingmultiple sclerosis at baseline and first-year folow-up

SARIDAŞ F.,MERCAN SARIDAŞ F.,KOÇE.R.,TURANÖ.F.
Heliyon, vol.10,no.5,2024 (SCI-Expanded)
XI. Probable eculizumab-associated hepatotoxicity in a patientwith neuromyelitis optica: a case reportProbable eculizumab-associated hepatotoxicity in a patientwith neuromyelitis optica: a case report
EmineRabiaK.,Ömer FarukT.,Furkan S.,LazrakE.S.,OzenP.A.,TuncerA.
INTERNATIONAL JOURNALOFNEUROSCIENCE,vol.134,no.11,pp.1205-1209,2024 (SCI-Expanded)
XI. CLIPPERS SyndromeCLIPPERS Syndrome
SARIDAŞ F.,KOÇE.R.,ÖZPARR.,HAKYEMEZB.,TURANÖ.F.
NeurologicalSciences andNeurophysiology,vol.41,no.2,pp.115-117,2024 (SCI-Expanded)
XII. Covid-19 infection as a possible risk factor for longitudinaly extensive transversemyelitis!Covid-19 infection as a possible risk factor for longitudinaly extensive transversemyelitis!
KOÇE.R.,TURANÖ.F.,MengucB.
INTERNATIONAL JOURNALOFNEUROSCIENCE,vol.134,no.2,pp.193-196,2024 (SCI-Expanded)
XIV. Howmuch are we understandable? The Efect of Health Literacy on Disease Perception andHowmuch are we understandable? The Efect of Health Literacy on Disease Perception and
Treatment Compliance inMultiple Sclerosis PatientsTreatment Compliance inMultiple Sclerosis Patients
KOÇE.R.,SARIDAŞ F.,MinazS.,TURANÖ.F.,ÖZKAYAG.,DemirciH.
MULTIPLE SCLEROSIS JOURNAL,pp.197,2023 (SCI-Expanded)
XV. Cladribine responsiveness in switched rrms patientsCladribine responsiveness in switched rrms patients
TepeN.,KOÇE.R.,SARIDAŞ F.,Akkoyun F.,SariU.S.,TURANÖ.F.,Kabay S.C.,Tokucoglu F.
MULTIPLE SCLEROSIS JOURNAL,pp.936,2023 (SCI-Expanded)
XVI. Index of cardiac-electrophysiological balance in relapsing-remitingmultiple sclerosis patientsIndex of cardiac-electrophysiological balance in relapsing-remitingmultiple sclerosis patients

treated with fingolimodtreated with fingolimod
Gunay-Polatkan S.,GuluG.,SIĞIRLID.,KOÇE.R.,AydinlarA.,TURANÖ.F.
MULTIPLE SCLEROSISANDRELATEDDISORDERS,vol.76,2023 (SCI-Expanded)
XVI. mRNA versus inactivated virus COVID-19 vaccines inmultiple sclerosis: Humoral responses andmRNA versus inactivated virus COVID-19 vaccines inmultiple sclerosis: Humoral responses and
protectivity-Does itmater?protectivity-Does itmater?
TütüncüM.,Demir S.,ArslanG.,DinçÖ.,Şen S.,GÜNDÜZT.,UzunköprüC.,GümüşH.,TütüncüM.,AkçinR.,etal.
MULTIPLE SCLEROSISANDRELATEDDISORDERS,vol.75,2023 (SCI-Expanded)
XVII. Index of cardiac-electrophysiological balance in relapsing–remitingmultiple sclerosis patientsIndex of cardiac-electrophysiological balance in relapsing–remitingmultiple sclerosis patients
treated with fingolimodtreated with fingolimod
GünayPolatkanŞ.,GülüG.,SigirliD.,KocE.R.,TuranÖ.F.,AydinlarA.
MULTIPLE SCLEROSISANDRELATEDDISORDERS,vol.76,pp.1-5,2023 (SCI-Expanded)
XIX. The Efect of Smoking on Inactivated andmRNA Vaccine Responses Applied to Prevent COVID-19 inThe Efect of Smoking on Inactivated andmRNA Vaccine Responses Applied to Prevent COVID-19 in
Multiple SclerosisMultiple Sclerosis
Şen S.,ArslanG.,TütüncüM.,Demir S.,DinçÖ.,GÜNDÜZT.,UzunköprüC.,GümüşH.,TütüncüM.,AkçinR.,etal.
NOROPSIKIYATRIARSIVI-ARCHIVESOFNEUROPSYCHIATRY,vol.60,no.3,pp.252-256,2023 (SCI-Expanded)
XX. Eficacy of Accelerated Vaccination against Hbv to Achieve Antibody formation inMultiple SclerosisEficacy of Accelerated Vaccination against Hbv to Achieve Antibody formation inMultiple Sclerosis
Patients Receiving Anti-Cd20 TherapyPatients Receiving Anti-Cd20 Therapy
KOÇE.R.,TURANÖ.F.,SARIDAŞ F.,MENGÜÇB.,MİNAZ S.N.,ÖZKAYAG.
Annals of IndianAcademyofNeurology,vol.26,no.5,pp.697-701,2023 (SCI-Expanded)
XXI. Pituitary Involvement as a PrimaryManifestation of Granulomatosis with PolyangitisPituitary Involvement as a PrimaryManifestation of Granulomatosis with Polyangitis
KOÇE.R.,GÜLLÜG.,GÜNERA.,Tolunay S.,ÖZPARR.,DALKILIÇH.E.
NEUROLOGY INDIA,vol.70,no.3,pp.1251-1253,2022 (SCI-Expanded)
XXI. Efects of quarantine applied during the COVID-19 pandemic onmental health and quality of life inEfects of quarantine applied during the COVID-19 pandemic onmental health and quality of life in
patients withmultiple sclerosis and healthy controlspatients withmultiple sclerosis and healthy controls
KOÇE.R.,DemirA.,TopalogluE.,TURANÖ.F.,OzkayaG.
NEUROLOGICAL SCIENCES,vol.43,no.4,pp.2263-2269,2022 (SCI-Expanded)
XXII. Gabapentin treatment in notalgia paresthetica: a preliminary reportGabapentin treatment in notalgia paresthetica: a preliminary report
Tan F.U.,KocR. S.,DurmazE.E.O.,AkyurekF.T.
INTERNATIONAL JOURNALOFDERMATOLOGY,vol.59,no.4,2020 (SCI-Expanded)
XXIV. Afective Temperament Profiles in Patients withMultiple Sclerosis: Association withMood DisordersAfective Temperament Profiles in Patients withMultiple Sclerosis: Association withMood Disorders
OzkanA.,AltinbasK.,KocE.R.,SenH.M.,KaramanH. I.o.
NOROPSIKIYATRIARSIVI-ARCHIVESOFNEUROPSYCHIATRY,vol.53,no.4,pp.311-316,2016 (SCI-Expanded)
XXV. Selenium protects cerebral cels by cisplatin induced neurotoxicitySelenium protects cerebral cels by cisplatin induced neurotoxicity
KaraveliogluE.,BoyaciM.G.,SimsekN.,SonmezM.A.,KocR.,KARADEMİRM.,GuvenM.,EserO.
ACTACIRURGICABRASILEIRA, vol.30,no.6,pp.394-400,2015 (SCI-Expanded)
XXVI. An Experimental Comparison of the Efects of Propolis, Curcumin, andMethylprednisolone on CrushAn Experimental Comparison of the Efects of Propolis, Curcumin, andMethylprednisolone on Crush
Injuries of the Sciatic NerveInjuries of the Sciatic Nerve
Yuce S.,GokceE.C., IsikdemirA.,KocE.R.,CemilD.B.,GokceA.,SargonM.F.
ANNALSOF PLASTIC SURGERY, vol.74,no.6,pp.684-692,2015 (SCI-Expanded)
XXVI. Ganglion Cel-Inner Plexiform Layer Thickness in PatientsWith Parkinson Disease and AssociationGanglion Cel-Inner Plexiform Layer Thickness in PatientsWith Parkinson Disease and Association
With Disease Severity and DurationWith Disease Severity and Duration
SariE.,KocR.,YaziciA.,SahinG.,Ermis S. S.
JOURNALOFNEURO-OPHTHALMOLOGY,vol.35,no.2,pp.117-121,2015 (SCI-Expanded)
XXVII. Proconvulsant Efect of NUCB2/Nesfatin-1Proconvulsant Efect of NUCB2/Nesfatin-1
ErkenH.A.,KocE.R.,ErkenG.,GencO.,CelikH.T.,GokceE.C.,AyadaC.,TurgutS.,TurgutG.

INTERNATIONAL JOURNALOF PEPTIDERESEARCHANDTHERAPEUTICS,vol.21,no.1,pp.29-38,2015 (SCI-
Expanded)

XXIX. Migraine-like headache in cerebral venous sinus thrombosisMigraine-like headache in cerebral venous sinus thrombosis
Tan F.U.,Telioglu S.,KocR.S.,LeventogluA.
NEUROLOGIA INEUROCHIRURGIAPOLSKA, vol.49,no.1,pp.78-80,2015 (SCI-Expanded)
XXX. Is rosuvastatin protective against on noise-induced oxidative stress in rat serumIs rosuvastatin protective against on noise-induced oxidative stress in rat serum

KocE.R.,ErsoyA., IlhanA.,ErkenH.A.,Sahin S.
NOISE&HEALTH, vol.17,no.74,pp.11-16,2015 (SCI-Expanded)
XXXI. A comparison of hair and serum trace elements in patients with Alzheimer disease and healthyA comparison of hair and serum trace elements in patients with Alzheimer disease and healthy
participantsparticipants
KocE.R., IlhanA.,AyturkZ.,AcarB.,GÜRLERM.,AltuntasA.,KarapirliM.,BodurA. S.
TURKISH JOURNALOFMEDICAL SCIENCES,vol.45,no.5,pp.1034-1039,2015 (SCI-Expanded)
XXXI. The efects and interactions of APOE and APH-1A polymorphisms in Alzheimer diseaseThe efects and interactions of APOE and APH-1A polymorphisms in Alzheimer disease
Acar CinletiB.,YardimciN.,AyturkZ., IlhanA.,KayaG.,AcarM.,KocE.R.,GunduzE.,GunduzM.
TURKISH JOURNALOFMEDICAL SCIENCES,vol.45,no.5,pp.1098-1105,2015 (SCI-Expanded)
XXXII. Borax Partialy Prevents Neurologic Disability and Oxidative Stress in Experimental Spinal CordBorax Partialy Prevents Neurologic Disability and Oxidative Stress in Experimental Spinal Cord
Ischemia/Reperfusion InjuryIschemia/Reperfusion Injury
RabiaE.R.,GokceE.C.,SonmezM.A.,NamusluM.,GokceA.,BodurA. S.
JOURNALOF STROKE&CEREBROVASCULARDISEASES,vol.24,no.1,pp.83-90,2015 (SCI-Expanded)
XXXIV. Diagnostic Accuracy Comparison of Artificial Immune Algorithms for Primary HeadachesDiagnostic Accuracy Comparison of Artificial Immune Algorithms for Primary Headaches
CelikU.,YurtayN.,KocE.R.,TepeN.,GuluogluH.,ErtasM.
COMPUTATIONALANDMATHEMATICALMETHODS INMEDICINE,2015 (SCI-Expanded)
XXXV. The increase ofmean platelet volume in patients with Alzheimer diseaseThe increase ofmean platelet volume in patients with Alzheimer disease
KocE.R.,UzarE.,CirakY.,ParlakDemir Y., IlhanA.
TURKISH JOURNALOFMEDICAL SCIENCES,vol.44,no.6,pp.1060-1066,2014 (SCI-Expanded)
XXXVI. Single dose vareniclinemay trigger epileptic activitySingle dose vareniclinemay trigger epileptic activity
ErkenH.A.,ErkenG.,SimsekH.,KorkutO.,KocE.R.,YavuzO.,GencO.
NEUROLOGICAL SCIENCES,vol.35,no.11,pp.1807-1812,2014 (SCI-Expanded)
XXXVI. The efects of anti-epileptic drugs on human erythrocyte carbonic anhydrase I and I isozymesThe efects of anti-epileptic drugs on human erythrocyte carbonic anhydrase I and I isozymes
KocE.R.,ErkenG.,BilenC.,SackesZ.,GencerN.
ARCHIVESOF PHYSIOLOGYANDBIOCHEMISTRY,vol.120,no.4,pp.131-135,2014 (SCI-Expanded)
XXXVII. Selenium partialy prevents cisplatin-induced neurotoxicity: A preliminary studySelenium partialy prevents cisplatin-induced neurotoxicity: A preliminary study
ErkenH.A.,KocE.R.,YaziciH.,YayA.,ÖNDERG.Ö.,SariciS.F.
NEUROTOXICOLOGY,vol.42,pp.71-75,2014 (SCI-Expanded)
XXXIX. Possible efects of rosuvastatin on noise-induced oxidative stress in rat brainPossible efects of rosuvastatin on noise-induced oxidative stress in rat brain
ErsoyA.,KocE.R.,Sahin S.,DuzgunU.,AcarB., IlhanA.
NOISE&HEALTH, vol.16,no.68,pp.18-25,2014 (SCI-Expanded)
XL. Brief Pain Inventory score identifying and discriminating neuropathic and nociceptive painBrief Pain Inventory score identifying and discriminating neuropathic and nociceptive pain
ErdemogluA.K.,KocR.
ACTANEUROLOGICA SCANDINAVICA,vol.128,no.5,pp.351-358,2013 (SCI-Expanded)
XLI. Neuromyelitis optica: atipic clinic presentationNeuromyelitis optica: atipic clinic presentation
KocE.R.,ErsoyA., IlhanA.
NEUROLOGICAL SCIENCES,vol.33,no.6,pp.1439-1442,2012 (SCI-Expanded)
XLI. Anterior interosseous nerve involvement in a patient due to weight lifting:MRI and EMG findingAnterior interosseous nerve involvement in a patient due to weight lifting:MRI and EMG finding
KocE.R.,CemerogluO.,AyturkZ., IlhanA.
NEUROLOGY INDIA,vol.60,no.5,pp.527-528,2012 (SCI-Expanded)
XLII. Validity and Reliability of the Turkish Self-Administered Leeds Assessment of Neuropathic SymptomsValidity and Reliability of the Turkish Self-Administered Leeds Assessment of Neuropathic Symptoms
and Signs (S-LANSS) Questionnaireand Signs (S-LANSS) Questionnaire
KocR.,ErdemogluA.K.
PAINMEDICINE,vol.11,no.7,pp.1107-1114,2010 (SCI-Expanded)

Articles Published in Other JournalsArticles Published in Other Journals
I. Immune Checkpoint Inhibitor-Associated TransverseMyelitisImmune Checkpoint Inhibitor-Associated TransverseMyelitis
SARIDAŞ F.,HojatiF.,KOÇE.R.,TURANÖ.F.
DUZCEMEDICAL JOURNAL=DÜZCETIPFAKÜLTESIDERGISI,vol.26,2024 (Scopus)

I. Evaluation of Factors Afecting ComplianceWith Disease-Modifying Treatments inMultiple SclerosisEvaluation of Factors Afecting ComplianceWith Disease-Modifying Treatments inMultiple Sclerosis
PatientsPatients
KOÇE.R.,Sarıdaş F.,TuranÖ.F.
UludağÜniversitesiTıp FakültesiDergisi,vol.50,no.1,pp.1-4,2024 (Peer-Reviewed Journal)
II. Fingolimod real life experience in non-naivemultiple sclerosis patientsFingolimod real life experience in non-naivemultiple sclerosis patients
SARIDAŞ F.,KOÇE.R.,ÖZKAYAG.,TURANÖ.F.
THEEUROPEANRESEARCH JOURNAL,2024 (Peer-Reviewed Journal)
IV. D Vitamininin Fingolimod Tedavisi AlanMultipl Skleroz Hastalar D Vitamininin Fingolimod Tedavisi AlanMultipl Skleroz Hastaları Üzerine Etkisinin Ara Üzerine Etkisinin Araştırılması
SARIDAŞ F.,LAZRAK S.H.,KOÇE.R.,TURANÖ.F.
UludağTıpDergisi,2023 (Peer-Reviewed Journal)

V. Sectoral and Quadrant Evaluation of the Peripapilary Retinal Nerve Fiber Layer and Ganglion Cel-Sectoral and Quadrant Evaluation of the Peripapilary Retinal Nerve Fiber Layer and Ganglion Cel-
inner Plexiform Layer Thickness in Patients withMultiple Sclerosisinner Plexiform Layer Thickness in Patients withMultiple Sclerosis

KOÇE.R.,SÖĞÜTLÜSARIE.,YaziciA.,SARIDAŞ F.,TURANÖ.F.
TURKISH JOURNALOFNEUROLOGY,vol.29,no.4,pp.282-286,2023 (ESCI)
VI. Varicela zoster virus infection due to Pfizer-BioNTechmRNA COVID-19 vaccine and sinovac vaccineVaricela zoster virus infection due to Pfizer-BioNTechmRNA COVID-19 vaccine and sinovac vaccine
in two relapsing-remitingmultiple sclerosis patients during fingolimod therapyin two relapsing-remitingmultiple sclerosis patients during fingolimod therapy
TURANÖ.F.,KÖSEOĞLUM.,KOÇE.R.
ElsevierBV,vol.2,2022 (Peer-Reviewed Journal)
VI. The COVID-19 from Neurological OverviewThe COVID-19 from Neurological Overview
AcarT.,DemirelE.A.,AFSARN.,AKÇALIA.,DemirG.A.,ALAGÖZA.N.,MengiT.A.,ARSAVAE.M.,Ayta S.,BebekN.,
etal.
TURKISH JOURNALOFNEUROLOGY,vol.26,no.2,pp.58-108,2020 (ESCI)
VII. Parkinson hastalığında gözya nda gözyaşı ozmolaritesi k ozmolaritesiParkinson hastal ırılma zaman lma zamanı ve schirmer de ve schirmer değerlerik
Söğütlü SarıE.,KoçE.R.,YazıcıA.,ŞahinG.,ÇakmakH.,KocatürkT.,Ermiş S. S.
TürkOftalmolojiDergisi,vol.1,no.1,2015 (Peer-Reviewed Journal)
IX. Brakiyal Pleksus ve Hastal Brakiyal Pleksus ve Hastalıkları
KOÇE.R.
FizikTedaviveRehabilitasyonKliniğiDergisi,vol.2,no.1,pp.12-21,2015 (NonPeer-Reviewed Journal)
X. Serebral inmeyi taklit eden spontan spinal epidural hematom olgusuSerebral inmeyi taklit eden spontan spinal epidural hematom olgusu
KOÇE.R.,ACARB.,AYTÜRKZ.,CEMİLD.B.,KÖSEHAND., İLHANA.
TURKISH JOURNALOFNEUROLOGY,vol.20,no.3,pp.95-97,2014 (Scopus)
XI. Efect of Serum 25 OHEfect of Serum 25 OH vitamin D OnMuscle Strengthand Balance Over 65 Years of Age A Crossvitamin D OnMuscle Strengthand Balance Over 65 Years of Age A Cross
Sectional StudySectional Study
CEMEROĞLUÖ.,KOÇE.R.,GÖKK.,PİŞTAVAKMEŞEP.,ÇAKIRBAYH.
TheNew JournalofMedicine,vol.31,no.2,pp.102-105,2014 (Peer-Reviewed Journal)
XI. Akut TransversMiyelitAkut TransversMiyelit On İki Olgunun ki Olgunun İncelenmesi ncelenmesiOn
AYTÜRKZ.,KOÇE.R.,ACARB., İLHANA.
YeniTıpDergisi,vol.31,no.1,pp.40-44,2014 (Peer-Reviewed Journal)
XII. Yüzme sonrasında geli nda gelişen karotis arter diseksiyonu olgusu heterozigotMTHFR C677T genheterozigotMTHFR C677T gen en karotis arter diseksiyonu olgusuYüzme sonras
mutasyonunun rolümutasyonunun rolü Olgu sunumuOlgu sunumu
ERSOYA.,KOÇE.R.,DÜZGÜNÜ., İLHANA.
TürkBeyinDamarHastalıklarıDergisi,vol.19,no.3,pp.103-107,2013 (Peer-Reviewed Journal)
XIV. Creutzfeldt Jacob s Disease presenting with psychiatric symptoms and severe itchingCreutzfeldt Jacob s Disease presenting with psychiatric symptoms and severe itching
KOÇE.R.,ACARB.,AYTÜRKZ.,CENGİZT.,DÜZGÜNÜ., İLHANA.
TürkNörolojiDergisi,vol.19,no.1,pp.25-27,2013 (Scopus)
XV. DifusionWeightedMRI of CreutzfeldtDifusionWeightedMRI of Creutzfeldt Jakob DiseaseJakob Disease
AKYELN.G.,ÇAKIRB.,KOÇE.R.,KÖSEHAND.,AKINK.,KÖKTENERA.,TEKŞAMM.
YeniTıpdergisi,vol.30,no.1,pp.72-74,2013 (Peer-Reviewed Journal)
XVI. İpratropium Bromür Salbutamol kulan pratropium Bromür ımına ba ğlı gelişen deliryum en deliryumSalbutamol kulan
KOÇE.R.,AYTÜRK Z.,ACARB.,CENGİZT.,DÜZGÜNÜ., İLHANA.
YeniTıpdergisi,vol.30,no.1,pp.12-14,2013 (Peer-Reviewed Journal)

XVI. Evaluation of sympathetic skin responses associated with the autonomic nervous system and fatigueEvaluation of sympathetic skin responses associated with the autonomic nervous system and fatigue
scores in patients withmultiple sclerosisscores in patients withmultiple sclerosis
BAYILYETİKŞ.,KOÇE.R.,ERDEMOĞLUA.K.
JournalofClinicalandExperimental Investigations,vol.3,no.4,pp.387-391,2012 (Peer-Reviewed Journal)
XVII. Sjögren Sendromunda Nörolojik TutulumSjögren Sendromunda Nörolojik Tutulum Review
KOÇE.R., İLHANA.
TürkiyeKlinikleri İmmünolojiRomatolojiözel,vol.5,no.1,pp.80-82,2012 (Peer-Reviewed Journal)
XIX. İlk bulgusu Epilepsi nöbeti olan primer Sjögren sendromu Olgu sunumuOlgu sunumu lk bulgusu Epilepsi nöbeti olan primer Sjögren sendromu
KOÇE.R.,DÜZGÜNÜ.,ERSOYA., İLHANA.
TURKISH JOURNALOFNEUROLOGY,vol.18,no.1,pp.33-35,2012 (Scopus)
XX. Epilepsili ve Sa Epilepsili ve Sağlıklı Bireylerin Kayg Bireylerin KaygıDepresyon ve Umutsuzluk Düzeylerinin Kar Depresyon ve Umutsuzluk Düzeylerinin Karşılaştırılması
KOÇE.R.,PİŞTAVAKMEŞEP.
TürkNörolojiDergisi,vol.14,no.4,pp.189-194,2011 (Scopus)
XXI. Akut Dilüsyonel Elektrolitİmbalans mbalansına Ba ğlı Gelişen İlk Nöbet ve Status Epileptikus Olgusu lk Nöbet ve Status Epileptikus OlgusuAkut Dilüsyonel Elektrolit
KOÇE.R.,ERSOYA., İLHANA.
EPILEPSI,vol.17,no.1,pp.14-16,2011 (ESCI)
XXI. Seksüel ilişki ile tetiklenen refleks epilepsi nöbetleri iki olgu sunumuiki olgu sunumu ki ile tetiklenen refleks epilepsi nöbetleriSeksüel ili
KOÇE.R.,KOÇA.
TURKISH JOURNALOFNEUROLOGY,vol.17,no.1,pp.51-54,2011 (Scopus)
XXII. Atipik klinik bulgular ile seyreden Fahr hastal Atipik klinik bulgular ile seyreden Fahr hastalığı İki olgu sunumu ki olgu sunumu
KOÇE.R.,TUNÇ S.
JournalofClinicalandExperimental Investigations,vol.1,no.1,pp.41-44,2010 (Peer-Reviewed Journal)
XXIV. Assessment of ovarian reserve and Doppler characteristics in patients withmultiple sclerosis usingAssessment of ovarian reserve and Doppler characteristics in patients withmultiple sclerosis using
immunomodulating drugsimmunomodulating drugs
ÇİLA.P.,LEVENTOĞLUA.,SÖNMEZERM.,KOÇE.R.,KULTUKO.
Journalof theTurkishGermanGynecologicalAssociation,vol.10,no.4,pp.213-219,2009 (Peer-Reviewed Journal)
XXV. Migrende IgE aracılı alerjinin rolü alerjinin rolüMigrende IgE arac
UYSAL TAN F.,KALPAKLIOĞLUA.F.,KOÇE.R.,TUNÇKOLM.
AstımAlerji İmmünoloji,vol.3,no.1,pp.10-15,2005 (ESCI)

Books
I. HIV Pozitif HastadaMiyelin Oligodendrosit Glikoprotein Antikoru ileHIV Pozitif HastadaMiyelin Oligodendrosit Glikoprotein Antikoru ile İlişkili Hastal kili Hastalık: Olgu Sunumu k: Olgu Sunumu
Eşliğinde Literatürün Gözden Geçirilmesi inde Literatürün Gözden GeçirilmesiE
KOÇE.R.,SARIDAŞ F.
in:ECOMS2023,DUMANAHMETTAŞKIN,YETKİNMEHMETFATİH,Editor,NobelTıpKitabevleri,pp.107-110,2024
I. HIV Pozitif HastadaMiyelin Oligodendrosit Glikoprotein Antikoru ileİlişkili Hastal kili Hastalık: Olgu Sunumu k: Olgu SunumuHIV Pozitif HastadaMiyelin Oligodendrosit Glikoprotein Antikoru ile
Eşliğinde Literatürün Gözden Geçirilmesi inde Literatürün Gözden GeçirilmesiE
KOÇE.R.,SARIDAŞ F.
in:ECOMS2023EducationalCases ofMultiple Sclerosis,YETKİNMEHMETFATİH,ETHEMOĞLUÖZLEM,DUMAN
AHMETTAŞKIN,Editor,NobelTıpKitabevleri, İstanbul,pp.107-110,2024
II. Primer Santral Sinir Sistemi Vasküliti 3 Olgunun Klinik, Tanı ve Tedavi Özelikleri ve Tedavi ÖzelikleriPrimer Santral Sinir Sistemi Vasküliti 3 Olgunun Klinik, Tan
SARIDAŞ F.,KOÇE.R.,TURANÖ.F.
in:ECOMS2023EducationalCases ofMultiple Sclerosis,YETKİNMEHMETFATİH,ETHEMOĞLUÖZLEM,DUMAN
AHMETTAŞKIN,Editor,NobelTıpKitabevleri, İstanbul,pp.68-69,2024

Papers Presented at Peer-Reviewed Scientific ConferencesPapers Presented at Peer-Reviewed Scientific Conferences
I. NMOSD VEMOGAD TANILI HASTALARDA AĞRININ, ANKS RININ, ANKSİYETE, DEPRESYON, UYKU VE YA YETE, DEPRESYON, UYKU VE YAŞAMNMOSD VEMOGAD TANILI HASTALARDA A

KALİTESİ ÜZERİNE ETK İSİNİN DE ĞERLENDİRİLMESİ
LazrakS.H.,KOÇE.R.,SARIDAŞF.,TURANÖ.F.,BİLGEN.,YETKİNM.F.,TUNÇA.,SEFEROĞLUM.,BAYDARC.
60.UlusalNörolojiKongresi,Antalya,Turkey,27November -02December 2024, (SummaryText)
I. ANTİ-MOG İLİŞKİLİ SEREBRAL KORT SEREBRAL KORTİKAL ENSEFAL KAL ENSEFALİTİN KL İNİK VE RADYOLOJ K VE RADYOLOJİK ÖZELL K ÖZEİKLERİ
MANAZOĞLUH.C.,DEMİR S.,ÇETİNKAYAD.,KILIÇA.K.,ÖZAKBAŞ S.,SARIDAŞ F.,KOÇE.R.,BALCIB.P.,TAŞKIRAN
E.,ACIRİ.,etal.
60.UlusalNörolojiKongresi,Antalya,Turkey,27November -02December 2024,pp.5, (SummaryText)
II. MOGAD (MİYELİN OL İGODENDROS GODENDROSİT GL İKOPROTE KOPROTEİN ANT İKORU İLE İLİŞKİLİ HASTALIK) HASTALIK)MOGAD (M
HASTALARINDA AĞRININ DE RININ DEĞERLENDİRİLMESİ: ÇOKMERKEZL : ÇOKMERKEZLİ ÇALIŞMA ÖN SONUÇLARI MA ÖN SONUÇLARIHASTALARINDA A
KOÇE.R.,LAZRAK S.,SARIDAŞ F.,BİLGEN.,TUNÇA.,SEFEROĞLUM.,YETKİNM.F.,BAYDARC.,TURANÖ.F.
MSDays2024,Muğla,Turkey,16October 2024, (FulText)
IV. Neurobehcet Syndrome As a GreatMimicker:Neurobehcet Syndrome As a GreatMimicker: Clinical, Demographic, and Radiological Features ofClinical, Demographic, and Radiological Features of
Neurobehcet Syndrome and Relationship with Other ClinicalManifestations of Behcet SyndromeNeurobehcet Syndrome and Relationship with Other ClinicalManifestations of Behcet Syndrome
KOÇE.R.,SARIDAŞ F.,GÜLLÜG.,TURANÖ.F.,COŞKUNB.N.,PEHLİVANY.,ÖZTÜRKF.,SARICAOĞLUH.,ÖZPARR.,
HAKYEMEZB.
ECTRIMS 2024,KOPENAG,Denmark,18 -20 September 2024,pp.695
V. SU ÇİÇEĞİ ENFEKSİYONU SONRASI AKUT D YONU SONRASI AKUT DİSSEMİNE ENSEFALOM NE ENSEFALOMİYELİT OLGUSU T OLGUSUSU Ç
SARIDAŞ F.,MesutG.,TURANÖ.F.,KOÇE.R.
TÜRKİYEMSDERNEĞİ2.NÖROİMMÜNOLOJİDETANIVEAYIRICITANISEMPOZYUMU, İzmir,Turkey,7 -09 June
2024
VI. MULTİPL SKLEROZ TEDAV PL SKLEROZ TEDAVİSİNDE D İMETİL FUMARATIN L FUMARATINİKİ YILLIK TÜRK YILLIK TÜRKİYE GERÇEK YA YE GERÇEK YAŞAM VER İSİ
TERZİM.,ŞEN S.,BECKMANNY.,KARABUDAKR.,HELVACIE.M.,YETKİNM.F.,UZUNKÖPRÜC.,TÜRKOĞLUR.,KOÇ
E.R.,BALCIF.B.,etal.
59.UlusalNörolojiKongresi,Antalya,Turkey,13 -18December 2023
VI. AQP4 Antikoru pozitif NMOSD Hastalarında Eculizumab klinik deneyimlerimiz nda Eculizumab klinik deneyimlerimizAQP4 Antikoru pozitif NMOSD Hastalar
KOÇE.R.,TURANÖ.F.
VII.MSDAYS, İZMİR-Çeşme,Turkey,16 -18October 2023
VII. Multipl Sklerozlu Hastalarda HastalıkModifiye edici Tedavilere Uyuymun De kModifiye edici Tedavilere Uyuymun Değerlendirilmesi erlendirilmesiMultipl Sklerozlu Hastalarda Hastal
SARIDAŞ F.,KOÇE.R.,TURANÖ.F.
NörolojideYaşamKalitesiSempozyumu,Turkey,22 -24 September 2023, (FulText)
IX. MULTİPLE SKLEROZDA OBEZ PLE SKLEROZDA OBEZİTE VE BESLENME TE VE BESLENMEMULT
KOÇE.R.
V.MS’de fizyoterapiveRehabilitasyon Sempozyumu,Konya,Turkey,16 -18 June 2023, (FulText)
X. MS’DE GELECEK TEDAVİLERMS’DE GELECEK TEDAV
KOÇE.R.
18.ULUDAĞNÖROLOJİ gÜNLERİ,Bursa,Turkey,09March2023, (FulText)
XI. MULTİPLE SKLEROZ HASTALARINDA OCREL PLE SKLEROZ HASTALARINDA OCRELİZUMAB HIZLI ZUMAB HIZLI İNFÜZYON DENEY NFÜZYON DENEYİMİ
KOÇE.R.,TURANÖ.F.
18.UludağNörolojiGünleri,Bursa,Turkey,09March2023
XI. Okrelizumab tedavisi alanMS hastalarında HBVaç nda HBVaçısından serasutatuslar ndan serasutatusları ve proflaksi gereksinimleri ve proflaksi gereksinimleriOkrelizumab tedavisi alanMS hastalar
KOÇE.R.,SARIDAŞ F.,MengüçB.,MİNAZ S.N.,TURANÖ.F.
58.UlusalNörolojiKongresi,Antalya,Turkey,19November 2022, (FulText)
XII. PRİMER SANTRAL S MER SANTRAL SİNİR S İSTEMİ VASKÜLİTİ 3 OLGUNUN KL 3 OLGUNUN KLİNİK, TANI VE TEDAV K, TANI VE TEDAVİ ÖZELLİKLERİ
SARIDAŞ F.,KOÇE.R.,TURANÖ.F.
EDUCATIONAL CASESOFMULTIPLE SCLEROSIS (ECOMS) 2022,Gaziantep,Turkey,07October 2022, (FulText)
XIV. İzole Santral Sinir Sistemi Tutulumu Olan Nörosarkoidoz Olgular zole Santral Sinir Sistemi Tutulumu Olan Nörosarkoidoz Olgularında NasalMukosa Biopsisinin nda NasalMukosa Biopsisinin
Tanıdaki Yeri daki YeriTan
KOÇE.R.,TURANÖ.F.
EskişehirNörolojiGünleri/3.NöroromatolojiSempozyumu,Eskişehir,Turkey,09 September 2022
XV. OPTİK NÖR İT H İKAYESİ OLANMULT OLANMULTİPLE SKLEROZ TANILI HASTALARDA RET PLE SKLEROZ TANILI HASTALARDA RETİNAL GANGL NAL GANGLİONOPT
HÜCRE-İÇ PLEKS Ç PLEKSİFORM TABAKA KOMPLEKS FORM TABAKA KOMPLEKSİNİN OPT İK KOHERENS TOMOGRAF K KOHERENS TOMOGRAFİ İ LEHÜCRE-

DEĞERLENDİRİLMESİ: SA ĞLIKLI KONTROL GRUBU LIKLI KONTROL GRUBUİLE KAR ŞILAŞTIRMADE
SÖĞÜTLÜSARIE.,KOÇE.R.
17.UludağNörolojiGünleri,Bursa,Turkey,03March2022, (FulText)
XVI. Nörobehçet Hastaliginda Spinal Kord TutulumuNörobehçet Hastaliginda Spinal Kord Tutulumu
KOÇE.R.,TURANÖ.F.
EskisehirNörolojiGünleriNöro-RomatolojiSempozyumu,Eskişehir,Turkey,3 -05 September 2021, (FulText)
XVI. Nörobehçet Hastalarının Klinik, Demografik ve Radyolojik Tutulum Özeliklerinin Gözden Geçirilmesi n Klinik, Demografik ve Radyolojik Tutulum Özeliklerinin Gözden GeçirilmesiNörobehçet Hastalar
KOÇE.R.,GÜLLÜG.,TURANÖ.F.
İstanbulDermato-RomatolojiGüncelemeZirvesi,Turkey,25 -27 June2021, (FulText)
XVII. – EBV enfeksiyonunu izleyenMOG antikor pozitif ADEM olgusu- EBV enfeksiyonunu izleyenMOG antikor pozitif ADEM olgusu
KOÇE.R.,TURANÖ.F.
3.UluslararasıTürkDünyasıMultiplSklerozKongresi,Turkey,2 -04April2021, (FulText)
XIX. COVID-19 PANDEMI DÖNEMININMULTIPLCOVID-19 PANDEMI DÖNEMININMULTIPL SKLEROZ HASTALARI VE SAĞLIKLI KONTROLLERINKONTROLLERIN LIKLISKLEROZ HASTALARI VE SA
YAŞAM KALITESI ÜZERINE ETKISI AM KALITESI ÜZERINEYA
KOÇE.R.,BİCANDEMİRA.,TOPALOĞLUE.,TURANÖ.F.,ÖZKAYAG.
3.UluslararasıTürkDünyasıMultiplSklerozKongresi,Turkey,2 -04April2021
XX. UZUN SEGMENT TRANSVERSM UZUN SEGMENT TRANSVERSMİYELİT OLGULARININ ET T OLGULARININ ETİYOLOJİK, RADYOLOJ K, RADYOLOJİK VE TEDAV K VE TEDAVİ
ÖZELLİKLERİNİN GÖZDEN GEÇ N GÖZDEN GEÇİRİLMESİ
GÜLLÜG.,KOÇE.R.,TURANÖ.F.
10.NöroimmünolojiOkulu,Turkey,29April2021, (FulText)
XXI. Dry eye parameter changes in diabetic patients with the presence of diabetic neuropathyDry eye parameter changes in diabetic patients with the presence of diabetic neuropathy
SÖĞÜTLÜSARIE.,YAZICIA.,ŞAHİNVURALG.,ERMİŞ S. S.,KURTH.,KOÇE.R.
XXXIICongress of theESCRS,Spain,05 September 2015
XXI. DİRENÇLİ EPİLEPSİLERE YAKLA LERE YAKLAŞIMD
KOÇE.R.
4.KÜÇABNÖROLOJİTOPLANTISI,Balıkesir,Turkey,16 -17May2015
XXII. Yaşlıda dü şme ve ilgili vakalar me ve ilgili vakalarYa
KOÇE.R.
8.AkademikGeriatriKongresi,Antalya,Turkey,16April2015
XXIV. Multipl Skleroz Ayırıcı Tanısında Beyin Omurilik S nda Beyin Omurilik Sıvısının Yeri Multipl Skleroz Ay
KOÇE.R.
MULTİPL SKLEROZAYIRICITANISINDA LABORATUVAR” SEMPOZYUMU,Çanakkale,Turkey,24October 2014, (Ful
Text)
XXV. Sıçan epilepsimodelinde cep telofonu radyasyonumaruziyetinin SCN1A geni üzerine etkileri çan epilepsimodelinde cep telofonu radyasyonumaruziyetinin SCN1A geni üzerine etkileriS
GÜLTOPK.,KOÇE.R., İLHANA.,GÜNDÜZE.
47.UlusalNörolojiKongresi,Turkey,25November 2011
XXVI. Epileptik Hastalarda Olayaİlişkin Uyar kin Uyarılmış Potansiyelerde Latans Farklar Potansiyelerde Latans Farklarının Önemi Var m n Önemi VarmıdırEpileptik Hastalarda Olaya
LEVENTOĞLUA.,ÖZMENEKÖ.,KOÇE.R.
Epilepsikongresi, İzmir-Çeşme,Turkey,4 -07 June 2008, (FulText)
XXVI. Kısa A ğrı Sorgulama Formu Türkçe Geçerlilik ve Güvenirlik Ön Çal Sorgulama FormuK Türkçe Geçerlilik ve Güvenirlik Ön Çalışma Sonuçlar ma Sonuçları
KOÇE.R.,ERDEMOĞLUA.K.
43.UlusalNörolojiKongresi,Turkey,10 -15November 2007

Metrics
Publication:113
Citation (WoS):271
Citation (Scopus):504
H-Index (WoS):10
H-Index (Scopus):14

Non Academic ExperienceNon Academic Experience
CizreDevletHastanesiNörolojiBölümü,Uzman doktor